Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
03/2003
03/13/2003WO2002039990A3 Method for screening anti-proliferative compounds and inhibiting tumor growth
03/13/2003WO2002038140A3 Therapeutic uses for ip3 receptor-mediated calcium channel modulators
03/13/2003WO2002036829A3 Methods of diagnosing, preventing and treating neurological disorders and neuronal injuries
03/13/2003WO2002036554A3 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis
03/13/2003WO2002036553A3 Substituted alkanoic acids
03/13/2003WO2002034293A3 Use of citric acid as antimicrobial agent or enhancer or as anticancer agent
03/13/2003WO2002032411A3 Combination of statins and sorbitol dehydrogenase inhibitors
03/13/2003WO2002031511A3 Modulation of ligand binding/enzymatic activity of alpha beta proteins
03/13/2003WO2002026822A3 Pumpcn compositions and uses thereof
03/13/2003WO2002024920A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
03/13/2003WO2002024179A3 Method for reducing toxicity of combined chemotherapies
03/13/2003WO2002022563A1 Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient
03/13/2003WO2002020757A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/13/2003WO2002020056A3 Methods and compositions for producing a neurosalutary effect in a subject
03/13/2003WO2002017949A3 Novel functions for dp214
03/13/2003WO2002016416A3 Diagnosis and treatment of cardiovascular conditions
03/13/2003WO2002015893A3 Treatment of wounds
03/13/2003WO2002014487A3 Adeno-associated virus-mediated delivery of angiogenic factors
03/13/2003WO2002013797A3 Therapeutic combination of a cetp inhibitor and atorvastatin
03/13/2003WO2002008401A3 Elongase genes and uses thereof
03/13/2003WO2002008284A3 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
03/13/2003WO2002006340A3 Tetraspan protein and uses thereof
03/13/2003WO2002005798A3 Pharmaceutical compositions for treating neurological disorders
03/13/2003WO2002000690A3 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
03/13/2003WO2001097848A3 Vitronectin receptor antagonist pharmaceuticals
03/13/2003WO2001096376A3 Pro-apoptotic fragments of the dengue virus envelope glycoproteins
03/13/2003WO2001088103A3 Compositions and methods for tissue dedifferentiation and regeneration
03/13/2003US20030050469 Induction of a Th1-like response in vitro
03/13/2003US20030050442 62 human secreted proteins
03/13/2003US20030050345 Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroximic acid derivative
03/13/2003US20030050337 Polymorphic B Form of 3-(cyclopropylmethoxy)-4-[4(methylsulfonyl)phenyl]-5,5- dimethyl-5H-furan-2-one
03/13/2003US20030050333 Improved bioavailability; anticarcinogenic
03/13/2003US20030050331 Cytotoxic agents
03/13/2003US20030050329 Synergistic combination comprising roflumilast and a PDE-3 inhibitor
03/13/2003US20030050325 Novel compounds of the indolecarboxylic family and use thereof
03/13/2003US20030050314 Treating bone disorder caused by osteoclasts, tumor growth and tumor metastasis, prophylaxis of cardiovascular disorders, nephropathies or retinopathies
03/13/2003US20030050310 Hydroxamic acid derivatives as proteinase inhibitors
03/13/2003US20030050309 A gelatinase inhibitor for modulating the activity of a dopamine, serotonin, or norepinephrine receptor or transporter
03/13/2003US20030050308 Eltoprazine hydrochloride (1-(2,3-dihyro-1,4-benzodioxin-5-yl) piperazine hydrochloride), a phenylpiperazine derivative
03/13/2003US20030050307 Treating certain psychiatric and neurological disorders; anxiety disorder, panic disorder, obsessive compulsive disorder, depression, social phobia and eating disorders, and psychosis
03/13/2003US20030050306 Novel heteroaryl derivatives, their preparation and use
03/13/2003US20030050304 Therapeutic compounds
03/13/2003US20030050303 Treating neutrophils and eosinophils in the tissue of the eye or nasal mucous membrane
03/13/2003US20030050300 Therapeutic 5-HT ligand compounds
03/13/2003US20030050299 An intermediates for enantiomeric synthesis cermamide-like inhibitors; producing antilipemic agents
03/13/2003US20030050298 A sulfonamide substituted diphenyl thiourea compounds treating a chemokine mediated disease
03/13/2003US20030050294 Controlled release formulation for preventing or treating risk factors for cardiovascular disease
03/13/2003US20030050293 Use of dehydroepiandrosterone, its precursors and derivatives, by oral administration, as hydrating agents with direct action
03/13/2003US20030050289 Combination of drospirenone and an estrogen sulphamate for HRT
03/13/2003US20030050284 Administering to a subject before the onset of an ischemic episode at daily dosages of 1-2 g of free cdp-choline
03/13/2003US20030050281 Analogs of galanthamine and lycoramine as modulators of nicotinic receptors
03/13/2003US20030050278 Agent and food for inhibiting IgE antibody
03/13/2003US20030050272 Purified rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A) and deoxyhypusine synthase nucleic acids and polypeptides
03/13/2003US20030050261 Immunostimulatory nucleic acid molecules
03/13/2003US20030050257 Sugar derivatives of hydromorphone, dihydromorphine and dihydroisomorphine, compositions thereof and uses for treating or preventing pain
03/13/2003US20030050251 A polypeptide which inhibits or reduces tumor progression and/or metastasis
03/13/2003US20030050250 Administering an aromatic dipeptide derivative with a chemotherapeutic agent to treat tumor metastasis, solid tumor growth, angiogenesis and other neoplasia diseases
03/13/2003US20030050249 Complexes of alpha-6 integrin subunits with small peptides and methods for treating indications resulting from modulation of integrin-mediated responses by altering signal transduction
03/13/2003US20030050248 Novel amino acid and peptide inhibitors of Staphylococcus virulence
03/13/2003US20030050242 Protein polymerization inhibitors and methods of use
03/13/2003US20030050234 Conotoxin peptide extracted from the venom of a marine snail, Conus magnus (cono=cone); disorders associated with voltage gated sodium ion channel; neuromuscular blocking agents; local anesthetics; neuroprotective agents; analgesics
03/13/2003US20030050222 Antineoplastic combinations
03/13/2003US20030049790 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof
03/13/2003US20030049725 Anti-TNF antibodies, compositions, methods and uses
03/13/2003US20030049706 Nucleotide sequences coding polypeptide for use in the diagnosis, treatment and prevention of bacterial infections
03/13/2003US20030049699 Polypeptide for use in the treatment of cell proliferation disorders
03/13/2003US20030049662 Oligonucleotides for use in the treatment of wounds, cardiovascular, cell proliferative and developmental disorders
03/13/2003US20030049643 G protein-coupled receptors for use in the treatment of cardiovascular, nervous system, angina pectoris, inflamatory bowel, allergies and gastrointestinal disorders
03/13/2003US20030049617 Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes
03/13/2003US20030049337 Using eucalyptus plant extract
03/13/2003US20030049281 Topical emulsion; quaternary ammonium salt emulsifier
03/13/2003US20030049279 Polysaccharide encapsualted antigen
03/13/2003US20030049266 Induce immunology response usin gpolynucleotide
03/13/2003US20030049258 Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle
03/13/2003US20030049255 Interleukin-1 receptors in the treatment of diseases
03/13/2003US20030049252 Controlling immunology response; autoimmune disease, antiallergens
03/13/2003US20030049245 Methods for sterilizing preparations of digestive enzymes
03/13/2003US20030049242 Decorated red blood cells
03/13/2003US20030049227 Antitumor, anticarcinogenic agents; using fusion protein
03/13/2003US20030049208 For delivering a medicant; product includes a coating having a medicament or agent; bioavailabilty; chewing gum product that releases caffiene for improved performance
03/13/2003US20030049203 Targeted nucleic acid constructs and uses related thereto
03/13/2003CA2483959A1 Method for treating alzheimer's disease using quinaldoyl-amine derivatives of oxo- and hydroxy-substituted hydrocarbons
03/13/2003CA2459957A1 Culture system for rapid expansion of human embryonic stem cells
03/13/2003CA2459937A1 Ncam binding compounds
03/13/2003CA2459584A1 Compositions and use thereof in the treatment of cancer
03/13/2003CA2459583A1 Compositions and methods of treatment of cancer
03/13/2003CA2459492A1 Anti-influenzal agent
03/13/2003CA2459348A1 Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions
03/13/2003CA2459346A1 Benzothiazepine derivatives
03/13/2003CA2459161A1 Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain
03/13/2003CA2459146A1 Treatment of dementia and memory disorders with anticonvulsants and acetylcholinesterase inhibitors
03/13/2003CA2459136A1 A caspase-8 binding protein, its preparation and use
03/13/2003CA2459077A1 Diagnosis of carcinomas
03/13/2003CA2459045A1 Antidiabetic extracts of artemisia dracunculus
03/13/2003CA2458926A1 Methods of treating infection by drug resistant bacteria
03/13/2003CA2458808A1 Aminopyrrole compounds as antiinflammatory agents
03/13/2003CA2458798A1 Method for reducing hypertension and heart failure
03/13/2003CA2458780A1 Targeted nucleic acid constructs and uses related thereto
03/13/2003CA2458677A1 Methods and compositions for treating inflammatory disorders
03/13/2003CA2458670A1 Bv8 nucleic acids and polypeptides with mitogenic activity
1 ... 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 ... 1564